BEFORE CytoDiff* IMPLEMENTATION, ALL SAMPLES WITH
FLAGS FOR WBC ABNORMALITIES UNDERGO MANUAL REVIEW
~ 75%
NORMAL
DxH 800 or
connected
Workcell
CBC/Diff
result
Validation
REMISOL
middleware
~ 25%
ABNORMAL
DxH SMS
All abnormals undergo
manual review (25%).
Reportable result
manual review (25%).
AFTER CytoDiff* IMPLEMENTATION, 95% OF SAMPLES CAN BE ANALYZED WITH AN AUTOMATED SYSTEM
Figures and illustration results may vary
~ 75%
NORMAL
DxH 800 or
connected
Workcell
CBC/Diff
result
REMISOL
middleware
Validation
~ 25%
ABNORMAL
Reportable result
~ 20%
REPORTABLE
CytoDiff
RESULT
+
SAMPLE PREPARATION
FOR REFLEX
CytoDiff TEST
AUTOMATED ANALYSIS
~ 5% NEED SLIDES
*CE marked. Not available in the U.S.
©2016 Beckman Coulter, Inc. All rights reserved. Beckman Coulter, the stylized logo and the
Beckman Coulter product and service names mentioned herein are trademarks or registered
trademarks of Beckman Coulter, Inc. in the United States and other countries.
For Beckman Coulter’s worldwide office locations and phone numbers, please visit
ww.beckmancoulter.com/contact
BR-51320
DxH SMS
A fraction of abnormals
undergo manual review
(5% vs. 25%!)